{
  "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
  "docSlug": "njj0K6xhOdjDOAwq28MP",
  "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
  "authorId": "Pitchdecks",
  "authorName": "Moderna",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.29,
  "pageNumber": 21,
  "pageCount": 39,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide shows a partial view of a larger pipeline table, focusing on pandemic flu candidates.",
  "elementsJson": [
    "headline_text",
    "data_table",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/21",
  "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "disclaimer",
      "text": "Abbreviations: GLP = good laboratory practice; IND = investigational new drug; CTA = clinical trial authorization; CMV = cytomegalovirus; CV = cardiovascular; HMPV = human metapneumovirus; PIV3 = parainfluenza virus 3; IL-12 = interleukin-12; VEGF-A = vascular endothelial growth factor A.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22632f48-60e6-4cf1-a94d-11f50bc424ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Clinical Trial Status",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-d521-73bf-9bb2-753f9174ec45",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.21
      },
      "kind": "table",
      "text": "Development Candidate (DC), Lead, Indication / Target, Formulation, GLP Toxicology, IND/CTA Filed, Ph I, Ph 2, Funding. mRNA-1440, Moderna, Influenza H10, In Licensed, Yes, Yes, Started Dec '15. mRNA-1851, Moderna, Influenza H7, In Licensed, Yes, Yes, Started May '16.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53a1ab9b-2a99-4e79-ace6-05f33971dc0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Our Pipeline – Pandemic Flu mRNA-1440 & mRNA-1851",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "973e224a-848a-4cf7-b099-eaa8fd51e414",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "901b73d7-1d4a-410d-add8-f04fac8cd7b0",
      "evidence": "Development Candidate (DC), Lead, Indication / Target, Formulation, GLP Toxicology, IND/CTA Filed, Ph I, Ph 2, Funding. mRNA-1440, Moderna, Influenza H10, In Licensed, Yes, Yes, Started Dec '15",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}